Pc
PeptideCalc
📈vs📈

Sermorelin vs Tesamorelin

Both are GHRH analogs that stimulate natural growth hormone production, but they differ in potency, regulatory status, and clinical applications.

MetricSermorelinTesamorelin
CategoryGrowth HormoneGrowth Hormone
Default Unitmcgmg
Vial Sizes3, 6, 9, 152, 5, 10
Dose Range100–500 mcg1–2 mg
FrequencyDaily before bedDaily (PM)
Stability28 days28 days
Powder StorageFreezer −20°CFreezer −20°C
ReconstitutedFridge 2–8°CFridge 2–8°C

Potency

Tesamorelin is significantly more potent than sermorelin on a milligram-for-milligram basis. It produces greater IGF-1 elevation and more pronounced visceral fat reduction in clinical trials. Sermorelin is the milder option with a gentler effect profile.

FDA Status

Tesamorelin (Egrifta) is FDA-approved for HIV-associated lipodystrophy — the only FDA-approved GHRH peptide. Sermorelin was previously FDA-approved (Geref) but the commercial product was discontinued in 2008. Both are available through compounding pharmacies with a prescription.

Dosing

Sermorelin: 100–500 mcg daily (micrograms). Tesamorelin: 1–2 mg daily (milligrams). Despite the different absolute amounts, tesamorelin's greater potency means it produces stronger GH stimulation per dose.

Best Use Cases

Sermorelin: first-line GH peptide for beginners, anti-aging protocols, those wanting gentle GH support with minimal risk. Tesamorelin: visceral fat reduction, stronger GH stimulation needed, users who didn't respond adequately to sermorelin.

⚖️ The Verdict

Start with sermorelin if you're new to GH peptides — it's milder with the longest safety track record. Move to tesamorelin if you need stronger GH stimulation or specific visceral fat reduction. Both are legitimate GHRH options; they just sit at different points on the potency spectrum.

More Comparisons